Could This Company Provide the Missing Link in Cancer Drugs Efficacy?

Reading Time: 2 minutes

INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.

Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed David Schaffer.

On a recent Price of Business Show, Host Kevin Price visited with David Schaffer, head of business development for SciTech Development (https://www.scitechdevelopment.com/).  SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer treatments. They have developed a powerful, new Drug Delivery Platform (SDP) that will revolutionize how safe and promising, yet challenged drugs, can be delivered to kill cancer cells. SciTech has developed its first, patented drug, ST-001-nanoFenretinide that combines SDP and the drug fenretinide as a broadly applicable anticancer drug. SciTech Development is in the pre-revenue clinical stage of development.

·        The SciTech Drug Delivery Platform or “SDP” is designed to safely deliver high concentrations of drugs to kill cancer cells.

·        SDP works by formulating drugs into very tiny spheres known as “nanovesicles”, which “trick” the cells into letting the drug inside, ultimately killing the cancer.

·        SDP can be engineered with other drugs, making them more effective and patentable.

·        ST-001 and newly engineered SDP drugs may be used alone or in combination with existing therapies.

ST-001 contains the active ingredient fenretinide, a drug with a well-documented safety profile in over 3000 patients. However, it does not easily dissolve in the body so it cannot get to the cancer cells in high enough doses to be effective, a problem solved by ST-001.

 

After achieving numerous milestones, the approved clinical trials are “Confirmatory” not “Exploratory”.  The current trial simply needs to confirm that ST-001 can transport the drug into the cancer cell safely, at the right dose, without toxic side effects, and provide beneficial patient outcomes.

 

SciTech Development has embarked on a well-designed crowd-funding initiative open to all investors. Please go to: https://www.startengine.com/scitechdevelopment for more information.

LISTEN TO THE INTERVIEW IN ITS ENTIRETY HERE:

 

The Price of Business is one of the longest running shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).

Share This:

About USA Daily Chronicles News 99 Articles
No articles on this site should be construed as the opinion of PriceofBusiness.com. Do your homework, get expert advice before following the advice on this or any other site.

Be the first to comment

Leave a Reply

Your email address will not be published.


*